nach oben

Erschienen in:

28.02.2018 | Original Paper

Enzyme linked immunosorbent assay for total potent estrogenic miroestrol and deoxymiroestrol of Pueraria candollei, a Thai herb for menopause remedy

verfasst von: Gorawit Yusakul, Tharita Kitisripanya, Thaweesak Juengwatanatrakul, Seiichi Sakamoto, Hiroyuki Tanaka, Waraporn Putalun

Erschienen in: Journal of Natural Medicines | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Miroestrol and deoxymiroestrol are the most potent phytoestrogens of Pueraria candollei var. mirifica, having been proved as an effective herb for menopausal symptoms in folk medicines and clinical trials. To ensure efficacy and safety of P. candollei var. mirifica involved in nutraceutical products being available worldwide, the content of potent phytoestrogens as active ingredients should be specified. Therefore, in this study, we produced a monoclonal antibody for total analysis of potent estrogenic miroestrol and deoxymiroestrol, for which an analytical method was developed using a procedure for an indirect competitive enzyme-linked immunosorbent assay. The antibody exhibited equal reactivity against miroestrol and deoxymiroestrol. The sensitivity of determination was in the range of 31.3–500 ng/ml with high precision. The analytical parameters, such as accuracy (99.6–106% recovery) and high correlation with a HPLC–UV method, indicated the reliability of analysis. This method is of high performance, and it is cheap to control optimal miroestrol and deoxymiroestrol doses of P. candollei var. mirifica nutraceutical products.

Nur mit Berechtigung zugänglich

Ingham JL, Tahara S, Dziedzic SZ (1989) Minor isoflavones from the roots of Pueraria mirifica. Z Naturforsch C Bio Sci 44:724–726CrossRef

Ingham JL, Tahara S, Dziedzic SZ (1988) Coumestans from the roots of Pueraria mirifica. Z Naturforsch C Bio Sci 43:5–10CrossRef

Chansakaow S, Ishikawa T, Seki H, Sekine K, Okada M, Chaichantipyuth C (2000) Identification of deoxymiroestrol as the actual rejuvenating principle of “Kwao Keur”, Pueraria mirifica. The known miroestrol may be an artifact. J Nat Prod 63(2):173–175CrossRef

Matsumura A, Ghosh A, Pope GS, Darbre PD (2005) Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol 94(5):431–443CrossRef

Dalal PK, Agarwal M (2015) Postmenopausal syndrome. Indian J Psychiatry 57(Suppl 2):S222–S232CrossRef

Virojchaiwong P, Suvithayasiri V, Itharat A (2011) Comparison of Pueraria mirifica 25 and 50 mg for menopausal symptoms. Arch Gynecol Obstet 284(2):411–419CrossRef

Okamura S, Sawada Y, Satoh T, Sakamoto H, Saito Y, Sumino H, Takizawa T, Kogure T, Chaichantipyuth C, Higuchi Y, Ishikawa T, Sakamaki T (2008) Pueraria mirifica phytoestrogens improve dyslipidemia in postmenopausal women probably by activating estrogen receptor subtypes. Tohoku J Exp Med 216(4):341–351CrossRef

Lamlertkittikul S, Chandeying V (2004) Efficacy and safety of Pueraria mirifica (Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: phase II study. J Med Assoc Thai 87(1):33–40PubMed

Chandeying V, Lamlertkittikul S (2007) Challenges in the conduct of Thai herbal scientific study: efficacy and safety of phytoestrogen, Pueraria mirifica (Kwao Keur Kao), phase I, in the alleviation of climacteric symptoms in perimenopausal women. J Med Assoc Thai 90(7):1274–1280PubMed

10.

Manonai J, Chittacharoen A, Theppisai U, Theppisai H (2007) Effect of Pueraria mirifica on vaginal health. Menopause 14(5):919–924CrossRef

11.

Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U (2008) Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause 15(3):530–535CrossRef

12.

Chandeying V, Sangthawan M (2007) Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study. J Med Assoc Thai 90(9):1720–1726PubMed

13.

Eisenberger A, Westhoff C (2014) Hormone replacement therapy and venous thromboembolism. J Steroid Biochem Mol Biol 142(Supplement C):76–82CrossRef

14.

Prentice RL (2014) Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Semin Reprod Med 32(6):419–425CrossRef

15.

Suwanvesh N, Manonai J, Sophonsritsuk A, Cherdshewasart W (2017) Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Menopause 24(2):210–215CrossRef

16.

Monthakantirat O, Sukano W, Umehara K, Noguchi H, Chulikhit Y, Matsumoto K (2014) Effect of miroestrol on ovariectomy-induced cognitive impairment and lipid peroxidation in mouse brain. Phytomedicine 21(11):1249–1255CrossRef

17.

Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S (2007) Pueraria mirifica, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas 56(3):322–331CrossRef

18.

Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S (2008) Preventive effects of Pueraria mirifica on bone loss in ovariectomized rats. Maturitas 59(2):137–148CrossRef

19.

Suthon S, Jaroenporn S, Charoenphandhu N, Suntornsaratoon P, Malaivijitnond S (2016) Anti-osteoporotic effects of Pueraria candollei var. mirifica on bone mineral density and histomorphometry in estrogen-deficient rats. J Nat Med 70(2):225–233CrossRef

20.

Chatuphonprasert W, Udomsuk L, Monthakantirat O, Churikhit Y, Putalun W, Jarukamjorn K (2013) Effects of Pueraria mirifica and miroestrol on the antioxidation-related enzymes in ovariectomized mice. J Pharm Pharmacol 65(3):447–456CrossRef

21.

Jearapong N, Chatuphonprasert W, Jarukamjorn K (2014) Miroestrol, a phytoestrogen from Pueraria mirifica, improves the antioxidation state in the livers and uteri of beta-naphthoflavone-treated mice. J Nat Med 68(1):173–180CrossRef

22.

Chivapat S, Chavalittumrong P, Rattanajarasroj S, Punyamung S (2005) Chronic toxicity of Pueraria mirifica in rats. Thai J Pharmacol 27(2–3):76–90

23.

Malaivijitnond S (2012) Medical applications of phytoestrogens from the Thai herb Pueraria mirifica. Front Med 6(1):8–21CrossRef

24.

Yusakul G, Putalun W, Udomsin O, Juengwatanatrakul T, Chaichantipyuth C (2011) Comparative analysis of the chemical constituents of two varieties of Pueraria candollei. Fitoterapia 82(2):203–207CrossRef

25.

Udomsuk L, Juengwatanatrakul T, Putalun W, Jarukamjorn K (2012) Bimodal action of miroestrol and deoxymiroestrol, phytoestrogens from Pueraria candollei var. mirifica, on hepatic CYP2B9 and CYP1A2 expressions and antilipid peroxidation in mice. Nutr Res 32(1):45–51CrossRef

26.

Udomsin O, Juengwatanatrakul T, Yusakul G, Putalun W (2015) Chromene stability: the most potent estrogenic compounds in White Kwao Krua (Pueraria candollei var mirifica) crude extract. J Funct Foods 19(Part A):269–277CrossRef

27.

Shimokawa S, Kumamoto T, Ishikawa T, Takashi M, Higuchi Y, Chaichantipyuth C, Chansakaow S (2013) Quantitative analysis of miroestrol and kwakhurin for standardisation of Thai miracle herb ‘Kwao Keur’ (Pueraria mirifica) and establishment of simple isolation procedure for highly estrogenic miroestrol and deoxymiroestrol. Nat Prod Res 27(4–5):371–378CrossRef

28.

Yusakul G, Udomsin O, Juengwatanatrakul T, Tanaka H, Chaichantipyuth C, Putalun W (2013) High performance enzyme-linked immunosorbent assay for determination of miroestrol, a potent phytoestrogen from Pueraria candollei. Anal Chim Acta 785(Supplement C):104–110CrossRef

29.

Yusakul G, Udomsin O, Juengwatanatrakul T, Tanaka H, Chaichantipyuth C, Putalun W (2013) Highly selective and sensitive determination of deoxymiroestrol using a polyclonal antibody-based enzyme-linked immunosorbent assay. Talanta 114(Supplement C):73–78CrossRef

30.

Kitisripanya T, Jutathis K, Inyai C, Komaikul J, Udomsin O, Tanaka H, Putalun W (2017) Development of an enzyme-linked immunosorbent assay for the detection of isomiroestrol, an identical marker, in White Kwao Krua using a monoclonal antibody. J Pharm Biomed Anal 137:229–234CrossRef

31.

Kitisripanya T, Krittanai S, Udomsin O, Jutathis K, Komaikul J, Juengwatanatrakul T, Sakamoto S, Tanaka H, Morimoto S, Putalun W (2017) Development of an enzyme-linked immunosorbent assay for determination of miroestrol using an anti-miroestrol monoclonal antibody. Planta Med 83(10):855–861CrossRef

32.

Kitisripanya T, Jutathis K, Inyai C, Komaikul J, Udomsin O, Yusakul G, Tanaka H, Putalun W (2016) Anti-miroestrol polyclonal antibodies: a comparison of immunogen preparations used to obtain desired antibody properties. J Nat Med 70(2):296–299CrossRef

33.

Rajesh K, Rana KV, Suri CR (2013) Characterization of hapten-protein conjugates: antibody generation and immunoassay development for pesticides monitoring. Bionanoscience 3(2):137–144CrossRef

34.

Lee JH, Kim JY, Cho S-H, Jeong JH, Cho S, Park HJ, Baek SY (2017) Determination of miroestrol and isomiroestrol from Pueraria mirifica (White Kwao Krua) in dietary supplements by LC–MS–MS and LC–Q-Orbitrap/MS. J Chromatogr Sci 55(3):214–221PubMed

35.

Sookvanichsilp N, Soonthornchareonnon N, Boonleang C (2008) Estrogenic activity of the dichloromethane extract from Pueraria mirifica. Fitoterapia 79(7–8):509–514CrossRef

Titel: Enzyme linked immunosorbent assay for total potent estrogenic miroestrol and deoxymiroestrol of Pueraria candollei, a Thai herb for menopause remedy
verfasst von: Gorawit Yusakul
Tharita Kitisripanya
Thaweesak Juengwatanatrakul
Seiichi Sakamoto
Hiroyuki Tanaka
Waraporn Putalun
Publikationsdatum: 28.02.2018
Verlag: Springer Singapore
Erschienen in: Journal of Natural Medicines / Ausgabe 3/2018
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-018-1194-x

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Changes in content of triterpenoids and polysaccharides in Ganoderma lingzhi at different growth stages

Correction to: Cypripedin, a phenanthrenequinone from Dendrobium densiflorum, sensitizes non-small cell lung cancer H460 cells to cisplatin-mediated apoptosis

Cladosporamide A, a new protein tyrosine phosphatase 1B inhibitor, produced by an Indonesian marine sponge-derived Cladosporium sp.

Cellular mechanism for herbal medicine Junchoto to facilitate intestinal Cl−/water secretion that involves cAMP-dependent activation of CFTR

Determination of (E)-ferulic acid content in the root of Angelica acutiloba: a simple chemical evaluation method for crude drug quality control

Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway